Tuesday, July 21, 2026

Knowledge Files How We Source Search

#Duchenne Muscular Dystrophy

2 articles

All In on One Drug: How Santhera Pharmaceuticals' Single-Asset Strategy Mirrors a Global Biotech Dilemma

Pharmaceuticals & Biotech

All In on One Drug: How Santhera Pharmaceuticals' Single-Asset Strategy Mirrors a Global Biotech Dilemma

ViaNews Editorial Team•Feb 18, 2026

REGENXBIO's Duchenne Gene Therapy Targets 2027 Global Launch, Challenging Sarepta's Market Lead

Health & Biotech

REGENXBIO's Duchenne Gene Therapy Targets 2027 Global Launch, Challenging Sarepta's Market Lead

ViaNews Editorial Team•Feb 18, 2026